KINGSTON, Jamaica, Aug. 17, 2012 /PRNewswire-iReach/ -- Vyzin Inc a New Jersey based corporation and creator of the mobile health brand VESAG has announced a new partnership with Guardsman Alarms a member of the Guardsman Group Limited headquartered in Kingston, Jamaica. Guardsman Alarms will distribute and support Vyzin's VESAG product line to customers throughout Jamaica. VESAG is a Mobile b...
Vascular Solutions pays $3 million to acquire St. Jude Medical's Venture catheter, saying it's a planning a global re-lainch during Q2 2013. Vascular Solutions (NSDQ:VASC) said it spent $3 million on the Venture wire control catheter from St. Jude Medical (NYSE:STJ). News Well, Catheters, Mergers & Acquisitionsread more
CHAPEL HILL, N.C., Aug. 17, 2012 /- Regulatory Affairs groups face the monumental task of ensuring that companies comply with the plethora of global regulations pertaining to developing and marketing medical device products. These specialized groups largely rely on their own internal effectiveness and efficiencies to remain productive and support the organization's goals. Op...
Neusoft Positron Medical Systems Receives ISO Certification and CE Mark for their Attrius PET SystemAugust 17, 2012 10:15 am | by Bio-Medicine.Org | News | Comments
CHICAGO, Aug. 17, 2012 /- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, is pleased to announce that Neusoft Positron Medical Systems Co., Ltd., has received ISO certification (9001:2008 & 13485:2003) and CE Mark approval for their Attrius® PET Systems. Neusoft Positron Medical Systems is a joint venture between Neusoft Medical Syst...
Lessons from the front lines of medical device sales from the former vice president of sales at United States Surgical Corp. From 1989 to 1997 I had a front row seat on the rocketship called U.S. Surgical Corp. My ticket for the ride was punched in 1982, when I started as a sales rep at U.S. Surgical. I was fortunate enough to work through the ranks to senior director of sales and later became a VP of sales, responsible for half of the U.S. Over my more than 15 years with the firm, we went from just over $100 million in annual sales to $1.4 billion by 1997, the year before Tyco Healthcare acquired us for $3.3 billion. News Well, Salesforce Development and Trainingread more
Shares of St. Jude Medical closed down more than 4% yesterday after the FDA ordered it to run a 3-year study of its recalled Riata defibrillator leads. St. Jude Medical's (NYSE:STJ) shares dropped more than 4% yesterday after the FDA ordered the medical device company to run a 3-year surveillance program of its recalled Riata defibrillator leads, plus 3 other leads that are still on the market. News Well, Cardiac Rhythm Management, Recalls, Wall Street Beatread more
(saeru/Flickr) By Tom Ulrich When you look at an apple, no matter what variety, on the surface you can be pretty sure it's actually an apple. From there, you can make lots of assumptions about it, like how it will taste when you bite into it and what will happen if you plant the seeds in your yard. News Well, Neurological, Oncologyread more
Healthcare Expense Management Leader Patientco Receives $3.75M in funding led by BlueCross BlueShield Venture Partners and Sandbox IndustriesAugust 17, 2012 9:23 am | by Bio-Medicine.Org | News | Comments
ATLANTA, Aug. 17, 2012 /- Patientco, the leading healthcare expense management solution for patients and healthcare providers, announced the closing of its Series A funding round for $3.75 million led by BlueCross BlueShield Venture Partners and Sandbox Industries. Sandbox Industries Managing Director Tom Hawes will join Patientco's Board of Directors. Patientco simplifies th...
The nomination deadline is 4 p.m. ET on Wednesday, Sept. 26, 2012. PHILADELPHIA — The American Association for Cancer Research is now accepting nominations for its series of annual awards and lectureships. Scientists advancing the understanding and eradication of cancer through basic research, clinical care, therapeutics and prevention are eligible. Recipients will be honored at [...]
A duo of Democrats urge the FDA to "overhaul and streamline" recall and 510(k) databases to ensure new products aren't winning clearance on flawed designs. MASSDEVICE ON CALL — Congressmen Rep. Edward Markey (D-Mass.) and Sen. Jeff Merkely (D-Ore.) called on the FDA to "overhaul and streamline" its recalls and 510(k) premarket notification database. The legislators want the FDA to ensure that the data is "publicly available and easily searchable" so that it better serves the needs of medical device reviewers, manufacturers and patients, according to a letter they jointly issued to FDA medical devices director Dr. Jeffrey Shuren. News Well, FDA, On Callread more
MELVILLE, N.Y., Aug. 17, 2012 /- Henry Schein, Inc. (NASDAQ: HSIC ), the world's largest provider of health care products and services to office-based practitioners, today announced the appointment of Carol Raphael to the Company's Board of Directors. (Photo: http://photos.prnewswire.com/prnh/20120817/NY59052 ) Ms. Raphael brings a wealth of health care pol...
Biogen Idec is opening its doors and wallet to support science, technology, engineering and math (STEM) education. Through its foundation, the Biogen Idec Foundation Inc., the biotechnology business has provided a $100,000 grant to support Teach For America.
Draper Laboratory has formed a consortium of experts on post traumatic stress disorder (PTSD) to try and find biological indications of the disease, which affects both returning soldiers as well as civilians involved in accidents or assaults.
This letter provides the medical device user fee information, including fee rates and payment procedures, for Fiscal Year (FY) 2013 that runs from Oct. 1, 2012, through Sept. 30, 2013.
Thermo Fisher Scientific Inc. (NYSE: TMO) has entered into an underwriting agreement with Goldman, Sachs & Co., J.P. Morgan Securities LLC and RBS Securities Inc., to issue $500 million in senior notes at an interest rate of 1.850 percent, due 2018 and $800 million in senior notes at an interest rate of 3.150, due 2023.